Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081
Condition: Pulmonary Tuberculosis Interventions: Drug: WX-081; Drug: Bedaquiline; Drug: Standard treatment; Drug: Multi-drug background treatment (MBT) Sponsor: Shanghai Jiatan Pharmatech Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials